Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells
Baylor College of Medicine researchers extend the life and effectiveness of off-the-shelf, cancer-fighting immune T cells.
Read more
Search Results for: Heslop
CAR T cell therapy makes strides in tackling Hodgkin lymphoma
CAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read more
New insights into the mediators of patient recovery after CAR T cell immunotherapy
Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read more
Baylor College of Medicine Women of Science
From the Labs celebrates Women’s History Month with a series of posts highlighting the work of Baylor Women of Science. Here is the first post
Read more
Fighting back lymphoma resistance to treatment
T cell therapies have demonstrated encouraging results and benefits in patients with lymphoma resistant to chemotherapy, but, despite these advances, a large number of patients
Read more
“Off-the-shelf” cells are safe and effective to treat viral infections
A bone marrow transplant can be a life-saving treatment for patients with certain cancers and other serious illnesses that have not responded to conventional chemotherapies.
Read more
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responses
Treating cancer with the patient’s own immune cells has been successful. In particular, treating B cell malignancies with the patients’ own immune T cells modified
Read more